Zhang Ruiyi, Ge Xuefei, You Ke, Guo Yanli, Guo Hongyan, Wang Yanjie, Geng Li
Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China.
J Obstet Gynaecol Res. 2018 Nov;44(11):2077-2084. doi: 10.1111/jog.13760. Epub 2018 Aug 9.
The goal of this study was to analyze the specificity of p16/Ki67 dual staining in the detection of high-grade cervical lesions.
A total of 223 patients with an average age of 39 years old were enrolled in this study. All samples were analyzed by p16/Ki67 immunocytochemical dual staining, liquid-based cytology and high-risk human papillomavirus (HR-HPV) test. Diagnosis of each patient was verified by histopathological test.
The specificity of p16/Ki67 dual staining was 68.33%, which was significantly higher than that of cytology (38.33%) and HR-HPV test (21.67%) (P < 0.05) for CIN2+ detection. p16/Ki67 dual staining had similar sensitivity with HR-HPV test for CIN2+ detection (90.18% vs 93.87%, P = 0.286). In atypical squamous cells of undetermined significance (ASC-US) and low-grade squamous intraepithelial lesion (LSIL) cases, the specificity of p16/Ki67 dual staining was significantly higher than that of HPV test (66.67% vs 3.70%, P < 0.05) and its sensitivity was similar to that of HPV test for CIN2+ detection. The sensitivity and specificity of dual staining for CIN2+ detection in HR-HPV positive women were 90.85% and 70.21%, respectively, which were higher than those of cytology (83.01% and 42.55%) and HPV16/18 test (70.59% and 44.68%).
p16/Ki67 dual staining could improve the specificity of high-grade cervical lesions detection and have similar sensitivity to HPV test for CIN2+ detection. When triaging women with ASC-US or LSIL liquid-based cytology, compared with positive HR-HPV, the specificity of CIN2+ lesion detection was increased by p16/Ki67 dual staining. p16/Ki67 dual staining could reduce colposcopy referrals and avoid excessive diagnosis and treatment.
本研究旨在分析p16/Ki67双重染色在检测高级别宫颈病变中的特异性。
本研究共纳入223例平均年龄为39岁的患者。所有样本均采用p16/Ki67免疫细胞化学双重染色、液基细胞学检查和高危型人乳头瘤病毒(HR-HPV)检测进行分析。每位患者的诊断均通过组织病理学检查进行验证。
p16/Ki67双重染色检测CIN2+的特异性为68.33%,显著高于细胞学检查(38.33%)和HR-HPV检测(21.67%)(P<0.05)。p16/Ki67双重染色检测CIN2+的敏感性与HR-HPV检测相似(90.18%对93.87%,P=0.286)。在意义不明确的非典型鳞状细胞(ASC-US)和低级别鳞状上皮内病变(LSIL)病例中,p16/Ki67双重染色的特异性显著高于HPV检测(66.67%对3.70%,P<0.05),其敏感性与HPV检测检测CIN2+的敏感性相似。HR-HPV阳性女性中,双重染色检测CIN2+的敏感性和特异性分别为90.85%和70.21%,高于细胞学检查(83.01%和42.55%)以及HPV16/18检测(70.59%和44.68%)。
p16/Ki67双重染色可提高高级别宫颈病变检测的特异性,且在检测CIN2+方面与HPV检测具有相似的敏感性。在对ASC-US或LSIL液基细胞学检查的女性进行分流时,与HR-HPV阳性相比,p16/Ki67双重染色可提高CIN2+病变检测的特异性。p16/Ki67双重染色可减少阴道镜转诊,避免过度诊断和治疗。